Innovative Salivary Gland Biobank Offers Hope for Chronic Dry Mouth Treatment
Mayo Clinic scientists have developed a pioneering biobank of salivary gland tissue-organoids, opening new avenues for regenerating damaged glands and treating chronic dry mouth, especially in cancer patients.
Chronic dry mouth, medically known as xerostomia, affects millions worldwide and is often a debilitating side effect of salivary gland damage. This condition is particularly common among patients who have undergone radiation therapy for head and neck cancers, with nearly 70% experiencing permanent salivary gland damage. The resulting symptoms include difficulty chewing, tasting, speaking, swallowing, and an increased risk of tooth decay, significantly impairing quality of life.
In a groundbreaking development, researchers at Mayo Clinic have established the world’s first biobank of human salivary gland tissue-organoids. This biorepository provides a standardized collection of salivary gland samples, greatly advancing research efforts aimed at regenerating damaged glands and finding effective treatments for dry mouth. According to lead researcher Nagarajan Kannan, Ph.D., this resource addresses a critical barrier in the field—the limited availability of suitable, consistent salivary specimens for regenerative studies.
The biobank comprises samples from 208 donors and has already contributed to identifying biomarkers for saliva-producing cells and mapping the tissue origin of rare, self-renewing salivary cells. This platform enables scientists to develop personalized regenerative therapies, with potential to heal and grow new salivary gland tissue.
Additional research includes creating a radiation injury model to test regenerative approaches and exploring the cellular mechanisms underlying gland repair. This collaborative effort involves several departments at Mayo Clinic, including the Center for Regenerative Biotherapeutics.
The promise of this biobank extends beyond radiation-induced dry mouth, offering hope for patients who suffer from gland damage due to aging, medications, or diseases like diabetes, stroke, Alzheimer’s, and HIV/AIDS. With ongoing discoveries, future therapies may include cultivating regenerative cells and implanting new gland tissue, dramatically improving patient outcomes.
For more insights, refer to the study published in npj Regenerative Medicine: Establishment of salivary tissue-organoid biorepository. Source: https://medicalxpress.com/news/2025-05-salivary-gland-regenerative-biobank-combat.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Increasing Staff Levels in Aged Care: Does More Staffing Improve Care Quality?
While increased staffing levels in aged care homes meet targets, recent research questions whether it truly improves care quality. A nuanced approach focusing on workforce skills and support is crucial for better outcomes.
Study Finds Inflammatory Bowel Disease Impacts REM Sleep and May Signal Flares
A new study using wearable devices shows that inflammation in inflammatory bowel disease reduces REM sleep and may help predict disease flares, offering a non-invasive monitoring approach for chronic disease management.
Innovative Algorithm Enhances Fitness Tracking for People with Obesity
A new open-source algorithm developed by Northwestern University enhances the accuracy of fitness trackers for people with obesity, improving health monitoring and personalized interventions.
US Cancer Survivors Reach 18.6 Million and Projected to Surpass 22 Million by 2035
The U.S. cancer survivor population is projected to grow from 18.6 million in 2025 to over 22 million by 2035, highlighting the need for equitable care and survivorship support.